Collagen Solutions (COS)

 

COS Share PerformanceMore

52 week high7.2500 20/10/16
52 week low4.2500 03/10/17
52 week change -2.7500 (-37.93%)
4 week volume1,500,924 23/09/17

Media for (COS)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Hardman Research: Engineering towards CE Mark

RNS Number: 4611R Collagen Solutions PLC 21 September 2017 Hardman Research: Engineering towards CE Mark ChondroMimetic: Engineering towards CE Mark - Collagen Solutions is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, research, and regenerative medicine. A number of investme...

Study Update Patient Assessments Completed

RNS Number: 3626R Collagen Solutions PLC 21 September 2017 Collagen Solutions Plc (the "Company" or the "Group") ChondroMimetic Study Update Patient Assessments Completed, Analysis Ongoing Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-v...

Collagen Solutions to present at Hardman forum

Collagen Solutions chief executive Jamal Rushdy will be presenting at an investor evening hosted by Hardman & Co at DW...

Presenting at the Hardman Investor Forum

RNS Number: 9605Q Collagen Solutions PLC 18 September 2017 Collagen Solutions Plc (the "Company" or the "Group") Presenting at the Hardman Investor Forum Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that Jamal...

Issue of Equity

RNS Number: 4331Q Collagen Solutions PLC 12 September 2017 12 September 2017 Collagen Solutions Plc (the "Company" or "Collagen Solutions") Issue of Equity Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that it has all...

Collagen shareholders pass all resolutions at AGM

Collagen Solutions has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 1:0...

Result of AGM

RNS Number: 3047P Collagen Solutions PLC 30 August 2017 Collagen Solutions Plc (the "Company" or the "Group") Collagen Solutions plc ("Collagen Solutions", the "Company" or the "Group") Result of AGM Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices ...

Collagen Solutions sees progress on key initiatives

Collagen Solutions' recent progress on its key initiatives for this fiscal year will be highlighted by chief executive Jamal Ru...

Fundamental DataMore

EPS-0.95
Dividend yield0 %

Latest discussion posts More

  • Video: COS presentation at Hardman

    Investor presentation by Collagen Solutions CEO Jamal Rushdy at the Hardman & Co?s Investors Forum 20th September ...
    28-Sep-2017
    piw
  • Panmure Gordon note - Research Tree

    Read Panmure Gordon & Co's note on COLLAGEN SOLUTIONS PLC (COS), out this morning, by visiting https://www.research-tree.com/company/GB00B94T6Y14 "Collagen Solutions has ...
    3-May-2016
    FoxRed
  • Panmure Gordon note - Research Tree

    Read Panmure Gordon & Co's note on COLLAGEN SOLUTIONS, out this morning, by visiting https://www.research-tree.com/company/GB00B94T6Y14 "Collagen Solutions announced yesterday ...
    27-Apr-2016
    FoxRed

Users' HoldingsMore

Users who hold Collagen Solutions also hold..
OPTIBIOTIX H.28%
METAL TIGER28%
LLOYDS GRP.28%
VECTURA23%
CONCEPTA23%

Codes & Symbols

ISINGB00B94T6Y14
SymbolsCOS, LSE:COS, COS.L, COS:LN, LON:COS, XLON:COS